The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000

S S Richter1, K P Heilmann, S L Coffman

  • 1Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA. sandra-richter@uiowa.edu

Insights

Penicillin-resistant Streptococcus pneumoniae (PRSP) in the US primarily spread through a few dominant clones. These clones carry multiple antibiotic resistance genes, contributing to the rise of PRSP.

Area of Science:

  • Microbiology
  • Genetics
  • Epidemiology

Background:

  • Penicillin-resistant Streptococcus pneumoniae (PRSP) poses a significant public health challenge.
  • Understanding the genetic diversity and spread of PRSP is crucial for effective control strategies.

Purpose of the Study:

  • To determine the genetic relatedness of PRSP isolates in the United States.
  • To identify the dominant clones and their contribution to the emergence of PRSP.

Main Methods:

  • Utilized pulsed-field gel electrophoresis (PFGE) to analyze the genetic profiles of 672 PRSP isolates.
  • Covered national surveillance data from 1994-1995, 1997-1998, and 1999-2000.

Main Results:

  • Identified 104 distinct PFGE types, with 12 predominant types accounting for over 75% of isolates.
  • Five prevalent PFGE types were closely related to known widespread international clones.
  • Observed an increase in prevalence for 3 major PFGE types not related to recognized clones.
  • Found high rates of multidrug resistance (96%-100%) in 9 of the 12 predominant PFGE types.
  • Noted an increased prevalence of erythromycin resistance within 4 major PFGE types.

Conclusions:

  • The emergence of PRSP in the US during the 1990s is largely attributed to the human-to-human transmission of a limited number of clonal groups.
  • These dominant clones possess resistance determinants to multiple antibiotic classes, facilitating their widespread dissemination.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...